NCT06125197
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06125197
Title Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TILT Biotherapeutics Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92658 United States Details
UCLA Jonsson Comprehensive Cancer Center Santa Monica California 90404 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field